Comparison of Platelet-rich fibrin with Zinc oxide eugenol for the pain management of Alveolar Osteitis.
DOI:
https://doi.org/10.29309/TPMJ/2024.31.06.7565Keywords:
Alveolar Osteitis, Pain, Zinc Oxide EugenolAbstract
Objective: To estimate and associate the efficacy of platelet-Rich-Fibrin and zinc Oxide Eugenol in pain relief management patients presenting Alveolar Osteitis. Study Design: Prospective study. Setting: Department of Oral Surgery, Isra Dental College Hyderabad. Period: 1st March 2022 to 31st August 2022. Methods: Total 80 patients with alveolar osteitis were involved in the study. Patients were equally randomly categorized into two groups A and B, the intensity of pain was measured by VAS scale on prospective days Platelet-rich-fibrin treatment was given to group A, while Zinc Oxide Eugenol was given to group B. VAS score was recorded on every prospective day and results were recorded on an MS Excel sheet. Results: Out of 80 patients of AO, 28 were male and 52 were female patients, the mean age of females was 34.25 while the male mean age was 38.5. The mean pain score on 1st prospective day was 3.8 ± 1.3 for group A while group B Was 7.5 ± 1.7. On 3rd prospective day of the trial, the mean pain score was Group A was 2.9 ± 1.1 and Group B was 4.7 ± 1.3. On day 5th the mean pain score of Group A was 1.1 ± 0.9 and Group B was 3.0 ± 1.0 and on the last 7th prospective day the mean score of Group A was 1.0 ± 0.6 and Group B was 1.8 ± 0.8. Conclusion: The study observed PRF is more effective than ZOE in pain management patients presenting AO.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 The Professional Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.